KRISTINA SHEVLING: Open Payments
NPI 1962170712 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 46 payments from 12 companies in 2025. Trend: 2023 $104 · 2024 $234 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $251 |
| Janssen Biotech, Inc. | 4 | $214 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Ardelyx, Inc. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Lilly USA, LLC | 3 | $65 |
| PFIZER INC. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 5 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| GENZYME CORPORATION | 1 | $22 |
Products named: TREMFYA, LINZESS, DUPIXENT, SKYRIZI, IBSRELA, OMVOH, VOQUEZNA, XIFAXAN.
Industry payments across MO — which companies pay providers there.
